✦ LIBER ✦

Runx3 knockouts and stomach cancer

✍ Scribed by Levanon, Ditsa; Brenner, Ori; Otto, Florian; Groner, Yoram

Book ID: 110033647
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 87 KB
Volume: 4
Category: Article
ISSN: 1469-221X
DOI: 10.1038/sj.embor.embor868

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comment on Levanon et al., 'Runx3 knocko

Comment on Levanon et al., 'Runx3 knockouts and stomach cancer', in EMBO reports (June 2003)

✍ Bae, Suk Chul; Ito, Yoshiaki 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 27 KB

Expression of RUNX3 in skin cancers

✍ J. H. Lee; J.-K. Pyon; D. W. Kim; S. H. Lee; H. S. Nam; S. G. Kang; C. H. Kim; Y 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB

Frequent loss of RUNX3 gene expression i

Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography

✍ Nakase, Y; Sakakura, C; Miyagawa, K; Kin, S; Fukuda, K; Yanagisawa, A; Koide, K; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 575 KB

Oncogenic role of RUNX3 in head and neck

Oncogenic role of RUNX3 in head and neck cancer

✍ Dr. Yasusei Kudo; Takaaki Tsunematsu; Takashi Takata 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

## Abstract Cumulative evidences show that Runt‐related transcription factor 3 (RUNX3) has a tumor suppressive role in various cancers. In particular, RUNX3 appears to be an important component of the transforming growth factor‐β (TGF‐β)‐induced tumor suppression pathway. Contrary to reports on thi

Cancer and the knockout mouse

✍ Wynford-Thomas, David; Kipling, David 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 158 KB

RUNX3 in oncogenic and anti-oncogenic si

RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers

✍ Kosei Ito 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 1 views

## Abstract The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critic